ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
UNII P89DR4NY54

Substance Identification & Data

This profile provides standardized clinical and technical data for Antihemophilic Factor, Human Recombinant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P89DR4NY54.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 139076-62-3 and the RxNorm Concept ID (RxCUI) 1300486. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
P89DR4NY54
CAS Registry Number
139076-62-3
RxNorm Concept ID
1300486

Detailed Substance Profile

Preferred Name
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
P89DR4NY54
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
C81123
National Cancer Institute reference terminology for clinical and research data.
INN ID
6959
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Antihemophilic Factor, Human Recombinant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OCTOCOG ALFA

Common Names & Synonyms

ANTIHEMOPHILIC FACTOR (RECOMBINANT)
ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN FREE METHOD
ANTIHEMOPHILIC FACTOR, HUM REC
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
ANTIHEMOPHILIC FACTOR, RECOMBINANT
ANTIHEMOPHILIC FACTOR, RECOMBINANT, MANUFACTURED PROTEIN-FREE
ANTIHEMOPHILIC FACTOR,RECOMBINANT
ANTIHEMOPHILIC FACTOR,RECOMBINANT [VANDF]
BLOOD COAGULATION FACTOR VIII HUMAN, GLYCOFORM .ALPHA.
FACTOR VIII (RDNA)
FACTOR VIII OCTOCOG ALFA [MI]
FACTOR VIII RECOMBIN
FACTOR VIII, RECOMBINANT [WHO-DD]
HUMAN FACTOR VIII RECOMBINANT
OCTOCOG ALFA [EMA EPAR]
OCTOCOG ALFA [INN]
OCTOCOG ALFA [JAN]
OCTOCOG ALFA [WHO-DD]
RECOMBINANT ANTIHEMOPHILIC FACTOR PREPARATION
RECOMBINANT ANTIHEMOPHILIC FACTOR VIII

Brand / Trade Names

ADVATE
HELIXATE FS
HELIXATE NEXTGEN
KOGENATE
KOGENATE BAYER
KOGENATE FS
KOVALTRY
RECOMBINATE

Technical Codes

BAY 14-2222
BAY 81-8973
BAY W 6240
BAY-14-2222
BAY81-8973
BAY-81-8973
BAY-W-6240

NDC Products Containing ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

Manufacturer Quick Index

→ Baxalta US Inc. 3
→ Baxter Healthcare Corporation 6
→ Bayer HealthCare LLC 5
→ Novo Nordisk 11
→ Takeda Pharmaceuticals Amercia, Inc. 7
→ Takeda Pharmaceuticals America, Inc. 12

Baxalta US Inc.

NDC Product

Recombinate
NDC 0944-2831

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Recombinate
NDC 0944-2832

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Recombinate
NDC 0944-2833

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued

Baxter Healthcare Corporation

NDC Product

Advate
NDC 0944-2941

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Advate
NDC 0944-2942

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Advate
NDC 0944-2943

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Advate
NDC 0944-2944

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Advate
NDC 0944-2945

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued
NDC Product

Advate
NDC 0944-2946

Generic Name
N/A
Dosage Form
N/A
Route
N/A
Marketing
BLA
Inactive / Discontinued

Bayer HealthCare LLC

NDC Product
Plasma Derivative

Kovaltry
NDC 0026-3821

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Kovaltry
NDC 0026-3822

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Kovaltry
NDC 0026-3824

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Kovaltry
NDC 0026-3826

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Kovaltry
NDC 0026-3828

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing

Novo Nordisk

NDC Product
Plasma Derivative

Novoeight
NDC 0169-7810

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Novoeight
NDC 0169-7815

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Novoeight
NDC 0169-7820

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Novoeight
NDC 0169-7825

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Novoeight
NDC 0169-7830

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Novoeight
NDC 0169-7850

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Esperoct
NDC 0169-8100

Generic Name
Antihemophilic Factor (recombinant), Glycopegylated-exei
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Esperoct
NDC 0169-8150

Generic Name
Antihemophilic Factor (recombinant), Glycopegylated-exei
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Esperoct
NDC 0169-8200

Generic Name
Antihemophilic Factor (recombinant), Glycopegylated-exei
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Esperoct
NDC 0169-8300

Generic Name
Antihemophilic Factor (recombinant), Glycopegylated-exei
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Esperoct
NDC 0169-8500

Generic Name
Antihemophilic Factor (recombinant), Glycopegylated-exei
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing

Takeda Pharmaceuticals Amercia, Inc.

NDC Product
Plasma Derivative

Adynovate
NDC 0944-4622

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Adynovate
NDC 0944-4623

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Adynovate
NDC 0944-4624

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Adynovate
NDC 0944-4625

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Adynovate
NDC 0944-4626

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Adynovate
NDC 0944-4627

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Adynovate
NDC 0944-4628

Generic Name
Antihemophilic Factor (recombinant) Pegylated
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing

Takeda Pharmaceuticals America, Inc.

NDC Product
Plasma Derivative

Recombinate
NDC 0944-2841

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Recombinate
NDC 0944-2842

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Recombinate
NDC 0944-2843

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Recombinate
NDC 0944-2844

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Recombinate
NDC 0944-2845

Generic Name
Antihemophilic Factor Recombinant
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3045

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3046

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3047

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3051

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3052

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3053

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Advate
NDC 0944-3054

Generic Name
Antihemophilic Factor (recombinant)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus